clinical study using siddha medicine for Atopic dermatitis

Phase II Non-randomized clinical study on Bala Karappan(Atopic Dermatitis) with the evaluation of siddha trial drug Yazhpanathennai(internal)and Nathaisoori ennai(external)in children. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071212

Enrollment

Registered

2024-07-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Yazhpanathennai (internal) and Nathaisoori Ennai (external): Yazhpanathennai 4ml once a day for 10 days and external application of Nathaisoori Ennai on affected area. Intervention2: Ya

Eligibility

Inclusion criteria

Inclusion criteria: Itching Erythema Papules Vesicles Oozing Crusting Scaling Lichenification

Exclusion criteria

Exclusion criteria: Psoriasis Scabies Photo dermatitis Ichthyosis vulgaris Pityriasis alba

Design outcomes

Primary

Measure	Time frame
Reduction in EASI score(Eczema Area Severity Index) Reduction in clinical symptoms like itching,papules,pustules, Oozing,scaling,lichenificationTimepoint: 10 Days	—

Secondary

Measure	Time frame
It is assessed by comparing the safety parameters before and after treatmentTimepoint: 10 Days	—

Countries

India

Contacts

Public ContactDr D Indrabala

Government Siddha Medical College Arumbakkam Chennai

cspriya2004@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026